Pretherapeutic inflammation status and cytokine profile may predict response to immunotherapy in NSCLC patients

被引：0
|
作者：
Kauffmann-Guerrero, D.
Kahnert, K.
Syunyaeva, Z.
Kiefel, R.
Tufman, A.
Huber, R. M.
机构：
[1] Univ Munich, LMU Klinikum, Dept Internal Med 5, Munich, Germany
[2] Univ Munich, LMU Klinikum, Thorac Oncol Ctr Munich TOM, Munich, Germany
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
40P
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [1] Survival of Patients with advanced NSCLC on Immunotherapy based on Cytokine Profile in Serum
    Schindler, H.
    Lusky, F.
    Elshiaty, M.
    Bozorgmehr, F.
    Kuon, J.
    Shah, R.
    Schneider, M.
    Eichhorn, F.
    Angeles, A.
    Janke, F.
    Kriegsmann, M.
    Kazdal, D.
    Kirchner, M.
    Stenzinger, A.
    Sultmann, H.
    Thomas, M.
    Christopoulos, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 97 - 97
  • [2] Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study
    Diego Kauffmann-Guerrero
    Kathrin Kahnert
    Rosemarie Kiefl
    Laura Sellmer
    Julia Walter
    Jürgen Behr
    Amanda Tufman
    Scientific Reports, 11
  • [3] Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study
    Kauffmann-Guerrero, Diego
    Kahnert, Kathrin
    Kiefl, Rosemarie
    Sellmer, Laura
    Walter, Julia
    Behr, Juergen
    Tufman, Amanda
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] Pretherapeutic inflammation markers and scores predict febrile neutropenia in SCLC patients
    Kauffmann-Guerrero, D.
    Kahnert, K.
    Syunyaeva, Z.
    Tufman, A.
    Huber, R. M.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 107 - 107
  • [5] Changes in cytokine profile may predict therapeutic efficacy of infliximab in patients with ulcerative colitis
    Sato, Shoko
    Chiba, Toshimi
    Nakamura, Shotaro
    Matsumoto, Takayuki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (10) : 1467 - 1472
  • [6] Tumor Mutation Burden Through Hybrid Capture - Circulating Tumor DNA May Predict Response to Immunotherapy in NSCLC
    Grinberg, R.
    Roisman, L.
    Geva, S.
    Lefterova, M.
    Quinn, K.
    Gutman, L. Soussan
    Dvir, A.
    Yair, R.
    Lanman, R.
    Mehta, D.
    Kiedrowski, L.
    Raez, L.
    Peled, N.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S459 - S459
  • [7] Blood cytokine changes in patients with advanced NSCLC receiving immunotherapy
    Schindler, H. L.
    Lusky, F.
    Gaissmaier, L.
    Daniello, L.
    Elshiaty, M.
    Bozorgmehr, F.
    Kuon, J.
    Shah, R.
    Schneider, M.
    Eichhorn, F.
    Baum, P.
    Angeles, A.
    Janke, F.
    Kriegsmann, M.
    Kazdal, D.
    Stenzinger, A.
    Sultmann, H.
    Thomas, M.
    Christopoulos, P.
    ANNALS OF ONCOLOGY, 2022, 33 : S61 - S62
  • [8] Resuscitation Status May Predict Mortality in Patients Admitted to the ICU Response
    Keegan, Mark T.
    Gajic, Ognjen
    Afessa, Bekele
    CHEST, 2013, 143 (03) : 876 - 876
  • [9] Biomarkers that may predict response to immunotherapy in ovarian malignancies
    Chin, Curtis D.
    Fares, Charlene M.
    Konecny, Gottfried E.
    Rao, Jianyu
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2020, 32 (01) : 84 - 90
  • [10] High Performance Radiomic Classifier to Predict the Response to Immunotherapy in Advanced NSCLC
    Mazzaschi, G.
    Scandino, R.
    Milanese, G.
    Pavone, C.
    Balbi, M.
    Ledda, R.
    Minari, R.
    Trentini, F.
    Bordi, P.
    Buti, S.
    Leonetti, A.
    Quaini, F.
    Sverzellati, N.
    Romanel, A.
    Tiseo, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1140 - S1141
12345